• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明膜病的纤溶酶缺陷

The fibrinolytic enzyme defect of hyaline membrane disease.

作者信息

LIEBERMAN J, KELLOGG F

出版信息

Calif Med. 1961 Nov;95(5):278-82.

PMID:14465183
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1574702/
Abstract

An investigation of the pulmonary fibrinolytic enzyme system in 31 infants who died with hyaline membrane formation was reviewed. There was complete lack of plasminogen activator activity in the lungs of 84 per cent of these infants. This phenomenon was shown to result from an abnormal inhibitor. A comparable inhibitor was found in normal placental tissue, and it is postulated that this inhibitor is released into the circulating blood as the result of placental infarction. Fibrin, a basic component of the hyaline membrane, is probably precipitated from a physiological capillary transudate associated with the formation of amniotic fluid by the lungs. The presence of an inhibitor of fibrinolysis would then result in the accumulation of intrapulmonary fibrin and the formation of hyaline membranes.

摘要

对31例死于透明膜形成的婴儿的肺纤维蛋白溶解酶系统进行了回顾性研究。这些婴儿中84%的肺部完全缺乏纤溶酶原激活物活性。已证明这种现象是由一种异常抑制剂导致的。在正常胎盘组织中发现了一种类似的抑制剂,据推测,这种抑制剂是由于胎盘梗死而释放到循环血液中的。透明膜的一种基本成分纤维蛋白,可能是从与肺羊水形成相关的生理性毛细血管渗出液中沉淀出来的。纤溶抑制物的存在会导致肺内纤维蛋白的积累和透明膜的形成。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b441/1574702/1b0429fd26dc/califmed00173-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b441/1574702/a0e67eb88de1/califmed00173-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b441/1574702/1b0429fd26dc/califmed00173-0062-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b441/1574702/a0e67eb88de1/califmed00173-0058-a.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b441/1574702/1b0429fd26dc/califmed00173-0062-a.jpg

相似文献

1
The fibrinolytic enzyme defect of hyaline membrane disease.透明膜病的纤溶酶缺陷
Calif Med. 1961 Nov;95(5):278-82.
2
The nature of the fibrinolytic-enzyme defect in hyaline-membrane disease.透明膜病中纤维蛋白溶解酶缺陷的本质。
N Engl J Med. 1961 Aug 24;265:363-9. doi: 10.1056/NEJM196108242650803.
3
Pathways of fibrin turnover in lavage of premature baboons with hyperoxic lung injury.高氧肺损伤早产狒狒灌洗中纤维蛋白周转途径
Am J Respir Crit Care Med. 1994 Mar;149(3 Pt 1):767-75. doi: 10.1164/ajrccm.149.3.8118648.
4
Fibrinolytic activity in the serum of infants with and without the hyaline membrane syndrome.
Acta Paediatr (Stockh). 1960 Nov;49:727-33. doi: 10.1111/j.1651-2227.1960.tb16079.x.
5
Pulmonary hyaline membrane; contamination of the lungs by blood-laden amniotic fluid in term infants delivered by cesarean section.肺透明膜;剖宫产分娩的足月儿肺部被含血羊水污染。
Obstet Gynecol. 1959 Sep;14:267-87.
6
Fibrinolytic acivity in lung tissue from neonates with hyaline membrane disease.患有透明膜病的新生儿肺组织中的纤溶活性。
Acta Paediatr Scand. 1973 Mar;62(2):149-57. doi: 10.1111/j.1651-2227.1973.tb08083.x.
7
FIBRINOLYSIN, FIBRIN AND HYALINE MEMBRANES.纤维蛋白溶酶、纤维蛋白与透明膜
Pediatrics. 1963 Nov;32:940-2.
8
Letter: Fibrinolytic activity in hyaline membrane disease.信函:透明膜病中的纤溶活性。
Acta Paediatr Scand. 1973 Nov;62(6):668-9. doi: 10.1111/j.1651-2227.1973.tb17084.x.
9
[Role of fibrin in the formation of hyaline membranes].[纤维蛋白在透明膜形成中的作用]
Pediatriia. 1971 Oct;50(10):58-61.
10
Role of fibrinolysis in development of hyaline membrane disease in newborn rabbits.纤维蛋白溶解在新生兔透明膜病发生中的作用。
Virchows Arch A Pathol Anat Histol. 1978 Jun 15;378(3):247-57. doi: 10.1007/BF00427363.

引用本文的文献

1
Plasminogen improves lung lesions and hypoxemia in patients with COVID-19.纤溶酶原可改善 COVID-19 患者的肺部病变和低氧血症。
QJM. 2020 Aug 1;113(8):539-545. doi: 10.1093/qjmed/hcaa121.
2
[Experimental fibrinolysis of tissues and studies on the problem of a relationship between fibrinolysis and the development of pulmonary hyaline membranes. Criticism of methods and development of a modification of the KSCN extraction method according to Astrup-Albrechtsen].[组织的实验性纤维蛋白溶解以及纤维蛋白溶解与肺透明膜形成之间关系问题的研究。对方法的批判以及根据阿斯特鲁普 - 阿尔布雷克森法改进硫氰酸钾提取法]
Arch Gynakol. 1967;204(1):59-67. doi: 10.1007/BF00668264.

本文引用的文献

1
ACTIVATION OF PROPLASMIN BY A FACTOR FROM MAMMALIAN TISSUE.来自哺乳动物组织的一种因子对纤溶酶原的激活作用。
J Clin Invest. 1950 Mar;29(3):317-24. doi: 10.1172/JCI102260.
2
The fetal lung, a source of amniotic fluid.胎儿的肺是羊水的一个来源。
Proc Soc Exp Biol Med. 1959 Aug-Sep;101:842-5. doi: 10.3181/00379727-101-25115.
3
A deficiency of pulmonary fibrinolysis in hyaline-membrane disease.透明膜病中肺纤维蛋白溶解功能的缺乏。
N Engl J Med. 1960 May 19;262:999-1004. doi: 10.1056/NEJM196005192622001.
4
The nature of the fibrinolytic-enzyme defect in hyaline-membrane disease.透明膜病中纤维蛋白溶解酶缺陷的本质。
N Engl J Med. 1961 Aug 24;265:363-9. doi: 10.1056/NEJM196108242650803.
5
Surface properties in relation to atelectasis and hyaline membrane disease.与肺不张和透明膜病相关的表面特性
AMA J Dis Child. 1959 May;97(5, Part 1):517-23. doi: 10.1001/archpedi.1959.02070010519001.
6
Clinical syndromes associated with deficient lung fibrinolytic activity: I. A new concept of hyaline-membrane disease.与肺纤维蛋白溶解活性不足相关的临床综合征:I. 透明膜病的新概念。
N Engl J Med. 1959 Mar 26;260(13):619-26. doi: 10.1056/NEJM195903262601301.
7
Obstructive factors in the pulmonary hyaline membrane syndrome in asphyxia of the newborn.
Pediatrics. 1958 Nov;22(5):847-56.
8
The fibrinolytic agents in saline extracts of human tissues.人体组织盐提取物中的纤溶因子。
Scand J Clin Lab Invest. 1958;10(1):91-6. doi: 10.3109/00365515809079923.
9
Estimation of the plasminogen activator and the trypsin inhibitor in animal and human tissues.动物和人体组织中纤溶酶原激活剂及胰蛋白酶抑制剂的测定。
Scand J Clin Lab Invest. 1957;9(3):233-43. doi: 10.3109/00365515709079963.
10
The fibrinolytic activity of human tissues.人体组织的纤溶活性。
Br J Haematol. 1957 Jul;3(3):284-91. doi: 10.1111/j.1365-2141.1957.tb05798.x.